Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000494:pharmacology*; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004193:Discrimination Learning / Q000187:drug effects*; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008635:Mescaline / Q000494:pharmacology; D008732:Methoxydimethyltryptamines / Q000494:pharmacology*; D012107:Research Design; D012701:Serotonin / Q000031:analogs & derivatives*; D012702:Serotonin Antagonists / Q000494:pharmacology; D013329:Structure-Activity Relationship
D000662:Amphetamines; D006213:Hallucinogens; D008732:Methoxydimethyltryptamines; D012702:Serotonin Antagonists; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D008635:Mescaline